Ranbaxy news

News Roundup: Ranbaxy Eyes Acquisitions In India

VC Circle - 50 minutes ago
GM Close To Stake Sale Deal With SAIC - General Motors India could be readying to offload as much as 50% equity stake to Chinese truck maker SAIC Motor Corp. SAIC has been eyeing entry into the ...

Ranbaxy eyes acquisitions to stay leader, Sobti says

Livemint - 40 minutes ago
New Delhi: Although its troubles with the US Food and Drug Administration (FDA) aren't over yet, India's biggest drug maker Ranbaxy Laboratories Ltd, controlled by Japan's Daiichi Sankyo Co., has ...

Indian Stock Market Closing Report : Markets Open In A Sea Of Red

istockAnalyst.com - 5 minutes ago
Indian markets opened on a weak note today as the benchmark indices opened way below the dotted line after yesterday's losses and have struggled to make any foray upwards since then. Most of Asia ...

Nifty turns volatile; BPCL, Ranbaxy up

Economic Times - 17 minutes ago
MUMBAI: Equities were off lows as buying emerged in oil & gas and auto majors in the last hour of trade of October series settlement day. At 3 pm, National Stock Exchange's Nifty was at 4795.70 ...

Ranbaxy-Daiichi working on a 3-year plan for synergising ops

Ranbaxy Laboratories Ltd price target is Rs319 by Angel Broking

Ranbaxy 3Q Net Profit Beats Forecast, Sales Fall

Wall Street Journal - 11 hours ago
By Rumman Ahmed BANGALORE (Dow Jones)--Ranbaxy Laboratories Ltd. (500359.BY) Monday handsomely beat market estimates for its third-quarter net profit as the drug maker benefited from cost cuts and ...

Tata Motors, Ranbaxy, IDBI, DLF, Sesa: India Equity Preview

Bloomberg - 27 minutes ago
By Rakteem Katakey and Rajhkumar K Shaaw Oct. 27 (Bloomberg) -- The following companies may have unusual price changes in India trading. Stock symbols are in parentheses and share prices are as of ...

Stocks to watch: Tata Motors, Era Infra, Ranbaxy...

Ranbaxy suffers 53% fall in US sales

Financial Times - 39 minutes ago
By James Lamont in New Delhi The financial pain inflicted by a US import ban on some of the products of Ranbaxy Laboratories, India's largest drugsmaker, continues to hurt the company a year after ...